JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 126 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $235,000 | +38.2% | 34,645 | +70.3% | 0.00% | – |
| Q4 2021 | $170,000 | -52.5% | 20,345 | -53.6% | 0.00% | -100.0% |
| Q3 2020 | $358,000 | +14.7% | 43,850 | -3.3% | 0.00% | 0.0% |
| Q2 2020 | $312,000 | -6.9% | 45,340 | -35.8% | 0.00% | 0.0% |
| Q1 2020 | $335,000 | -61.2% | 70,633 | -28.5% | 0.00% | 0.0% |
| Q4 2019 | $863,000 | +96.1% | 98,839 | -25.3% | 0.00% | 0.0% |
| Q3 2019 | $440,000 | -64.5% | 132,301 | -47.1% | 0.00% | -50.0% |
| Q2 2019 | $1,239,000 | -4.0% | 250,234 | +20.2% | 0.00% | 0.0% |
| Q1 2019 | $1,291,000 | +916.5% | 208,223 | +448.6% | 0.00% | – |
| Q4 2018 | $127,000 | -86.7% | 37,955 | -44.4% | 0.00% | -100.0% |
| Q2 2017 | $958,000 | – | 68,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
| Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
| TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
| Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
| Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
| PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
| Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
| RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |